Safety, Reactogenicity, and Immunogenicity Trial of STX-S SARS-CoV-2 Vaccine in Adults
Clinical trial NCT07095231 · COMPLETED
Trial details
- NCT number
- NCT07095231
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-11
- Primary completion
- 2026-06-16
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.